Emerging use of nanoparticles for the therapeutic ablation of urologic malignancies

Urologic Oncology: Seminars and Original Investigations

Volumn 26, Issue 1, 2008, Pages 93-96

  Stern, Joshua M ^a   Cadeddu, Jeffrey A ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Gold nanoshells; Laser ablation; Nanoparticles; Prostate cancer

Indexed keywords

GOLD; METAL; NANOPARTICLE; NANOSHELL;

HUMAN; INFRARED RADIATION; PRIORITY JOURNAL; REVIEW; URINARY TRACT DISEASE;

CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; GENE THERAPY; HUMANS; NANOPARTICLES; UROLOGIC NEOPLASMS;

EID: 37649014328     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.03.019     Document Type: Review

References (27)

1. Akduman B., Barqawi A.B., and Crawford E.D. Minimally invasive surgery in prostate cancer: Current and future perspectives. Cancer J 11 (2005) 355
2. Carroll P.R., Presti Jr. J.C., Small E., et al. Focal therapy for prostate cancer 1996: Maximizing outcome. Urology 49 (1997) 84
3. Cohen J.K., Miller R.J., Rooker G.M., et al. Cryosurgical ablation of the prostate: Two-year prostate-specific antigen and biopsy results. Urology 47 (1996) 395
4. Beerlage H.P., Thuroff S., Debruyne F.M., et al. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology 54 (1999) 273
5. Uchida T., Ohkusa H., Yamashita H., et al. Five years' experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 13 (2006) 228
6. Gardner T.A., and Koch M.O. Prostate cancer therapy with high-intensity focused ultrasound. Clin Genitourin Cancer 4 (2005) 187
7. Uchida T., Baba S., Irie A., et al. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: A multicenter study. Hinyokika Kiyo Acta Urologica Japonica 51 (2005) 651
8. Hacker A., Kohrmann K.U., Back W., et al. Extracorporeal application of high-intensity focused ultrasound for prostatic tissue ablation. BJU Int 96 (2005) 71
9. Pareek G., and Nakada S.Y. The current role of cryotherapy for renal and prostate tumors. Urol Oncol 23 (2005) 361
10. Matin S.F., Ahrar K., Cadeddu J.A., et al. Residual and recurrent disease following renal energy ablative therapy: A multi-institutional study. J Urol 176 (2006) 1973
11. Desai M.M., Aron M., and Gill I.S. Laparoscopic partial nephrectomy versus laparoscopic cryoablation for the small renal tumor. Urology 66 (2005) 23
12. Park S., Anderson J.K., Matsumoto E.D., et al. Radiofrequency ablation of renal tumors: Intermediate-term results. J Endourol 20 (2006) 569
13. McDougal W.S., Gervais D.A., McGovern F.J., et al. Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol 174 (2005) 61
14. Varkarakis I.M., Allaf M.E., Inagaki T., et al. Percutaneous radio frequency ablation of renal masses: Results at a two-year mean followup. J Urol 174 (2005) 456
15. Farokhzad O.C., Cheng J., Teply B.A., et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA 103 (2006) 6315
16. Yezhelyev M.V., Gao X., Xing Y., et al. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol 7 (2006) 657
17. El-Sayed I.H., Huang X., and El-Sayed M.A. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 239 (2006) 129
18. Loo C., Lowery A., Halas N., et al. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 5 (2005) 709
19. Maeda H., Fang J., Inutsuka T., et al. Vascular permeability enhancement in solid tumor: Various factors, mechanisms involved and its implications. Int Immunopharmacol 3 (2003) 319
20. Hirsch L.R., Stafford R.J., Bankson J.A., et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 100 (2003) 13549
21. Stern JM, Stanfield J, Lotan YA, et al. The efficacy of laser activated gold nanoshells to ablate prostate cancer cells in vitro. J Endourol [in press].
22. Yuan F., Leunig M., Huang S.K., et al. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 54 (1994) 3352
23. Litzinger D.C., Buiting A.M., van Rooijen N., et al. Effect of liposome size on the circulation time and intra-organ distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta 1190 (1994) 99
24. Kong G., Braun R.D., and Dewhirst M.W. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res 60 (2000) 4440
25. Northfelt D.W., Martin F.J., Working P., et al. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: Pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol 36 (1996) 55
26. O'Neal D.P., Hirsch L.R., Halas N.J., et al. Photothermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 209 (2004) 171
27. Everts M., Saini V., Leddon J.L., et al. Covalently linked Au nanoparticles to a viral vector: Potential for combined photothermal and gene cancer therapy. Nano Lett 6 (2006) 587